All volunteers provided written informed consent. This study was approved by the United Kingdom National Research Ethics Service (14/NW/1455). Thirty healthy adult volunteers were enrolled into the study. Sixteen volunteers (4 males and 12 females) were randomly selected for oral vaccination with live-attenuated S. Typhi (Ty21a; Vivotif). Three doses of a single oral capsule were taken on days 0, 2, and 4, approximately 1 hour before a meal, with a cold or lukewarm drink. Fourteen volunteers (2 males and 12 females) were randomly assigned to an unvaccinated control group.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.